PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/3670/6/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis
A health professional complained about a Novartis webinar registration webpage for Leqvio (inclisiran) titled: “Introducing an innovative approach to lipid management with inclisiran (Leqvio)”.…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3672/6/22
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Pfizer press release
A UK health professional complained about a Pfizer UK website press release in the media section (dated 31 December 2021) titled “PFIZER’S NOVEL COVID-19 ORAL ANTIVIRAL TREATMENT AUTHORISED FOR…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3659/6/22
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Teva breached Code over Ajovy HCP registration website
An anonymous, contactable complainant (self-described health professional) complained about a Teva UK registration website for HCPs to access recorded webinar highlights about Ajovy (fremanezumab):…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3645/5/22
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Proveca
A health professional complainant raised multiple concerns about the Sialanar (glycopyrronium bromide) dosing calculator app hosted at sialanar-website.firebaseapp.com, accessible via a promotional…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3665/6/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis breached Clause 6.1 and 5.1 over ‘1st line’ Entresto guideline claim lacking HFrEF definiti
An anonymous, contactable health professional complained about promotional claims for Entresto (sacubitril/valsartan) on Novartis’ health.novartis.co.uk website (UK | October 2021 materials). T…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3712/11/22
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
AbbVie breached ABPI Code over Rinvoq webpages
A health professional complained about two AbbViePro promotional webpages for Rinvoq (upadacitinib) in rheumatoid arthritis (RA) and psoriatic arthritis (PsA).The pages used imagery of young women …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3597/1/22
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
AstraZeneca
A UK health professional complained about: (1) a very senior AstraZeneca UK employee’s LinkedIn post linking to an iNews article about the Oxford/AZ Covid-19 vaccine; (2) a Reuters/LinkedIn post …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3679/8/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
CSL Vifor
An anonymous complainant challenged claims in a Ferinject (ferric carboxymaltose) promotional supplement published on the British Journal of Cardiology website (article: “Intravenous iron therapi…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3689/8/22
Social Media & Digital Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
CSL Vifor
CSL Vifor made a voluntary admission about promotional activities linked to the European Society of Cardiology – Heart Failure Association (ESC-HFA) conference (May 2022).A third party ran a sequ…
Clauses: 9.1,26.1
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3696/10/22
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
SOBI
An anonymous, non-contactable complainant challenged a corporate article sponsored by SOBI (Swedish Orphan Biovitrum Ltd) and published in print and online by The Guardian.The complainant alleged t…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3680/8/22
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Astellas
Astellas made a voluntary admission about undeclared transfers of value (ToVs) to healthcare organisations (HCOs) in 2019, 2020 and 2021 and to patient organisations (POs) in 2020 and 2021.The issu…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3662/6/22
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Novartis
An anonymous complainant challenged Novartis’ certification of a sponsored multiple sclerosis (MS) disease-awareness article published on MailOnline, including the share buttons and the content g…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3468/2/21
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi breached ABPI Code after uncertified internal email to salesforce about Toujeo patient materi
An anonymous, non-contactable complainant (describing themselves as a Sanofi employee) complained about an email sent to the salesforce titled “Toujeo news – Patient material & Digital camp…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3462/1/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim
An independent member of the Code of Practice Appeal Board (acting as a health professional) complained about the Pradaxa (dabigatran) HCP website (pradaxa.co.uk) regarding NVAF stroke prevention d…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3450/1/21
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck
An anonymous health professional complained about a Lundbeck Brintellix (vortioxetine) on-demand webinar and its event registration page titled “Clinical experience of emotional blunting and data…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3456/1/21
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Boehringer Ingelheim & Eli Lilly
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3459/1/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Napp
A UK health professional complained about an advertisement for a forthcoming promotional Invokana (canagliflozin) webcast hosted on Diabetes On The Net (ref UK-INV-2000106, January 2021).The webcas…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3460/1/21
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Novartis
A complainant (described themself as a health professional) challenged a Novartis Pharmaceuticals UK journal advertisement for Beovu (brolucizumab) placed in the December 2020 issue of the British …
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3469/2/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Takeda
An anonymous UK oncologist complained about a Takeda UK-organised, CPD-accredited online meeting: “ASH 2020 Highlights” (21 January 2021).The complainant said the content was good but there was…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3470/2/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous, contactable complainant (self-described health professional) complained about a four-frame digital banner advertisement for Seretide Evohaler (fluticasone/salmeterol) (ref PM-GB-FPS-W…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3473/2/21
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Alnylam
A contactable complainant alleged a LinkedIn post by an agency promoted Oxlumo (lumasiran) to the public, naming the product and describing it as the “first and only FDA-approved prescription med…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3500/4/21
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Employee complaint about representative training at Sanofi (No breach)
An anonymous, non-contactable employee complained about the quality of training provided when joining Sanofi as a diabetes representative.The complainant alleged that much of the training had been …
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3522/6/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
A health professional complained about promotion of Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) by GlaxoSmithKline UK Limited.Materials complained about:BTS Winter Meeting (Feb 2021) supp…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3526/6/21
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Leo Pharma
Leo Pharma UK voluntarily admitted that promotional emails for Innohep (tinzaparin) sent to UK healthcare professionals contained broken links to prescribing information.The emails used a clear, pr…
Clauses: NONE
2021 🔒 Subscribe
← Prev 6 7 8 9 10 11 12 Next → Page 9 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews